Human Regenerative Technologies, LLC (HRT®) is a biologics company focused on advancing the understanding and development of human amniotic and placental properties through scientific and clinical application.

HRT®’s product development team has over 50 years combined biologics experience. Our team’s research and development has enabled HRT® to emerge as a leader in natural human tissue allografts derived from amniotic membranes and placental connective tissues.

HRT® continues to advance biologic technologies derived from the dynamic placental system, which provides the foundation of the body’s various tissues and organs.

HRT® is proud to be accredited by the American Association of Tissue Banks® (AATB).